Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NVP-LAF237

Known as: NVP-LAF-237 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background Imatinib and second-generation tyrosine kinase inhibitors (TKIs) nilotinib and dasatinib have statistically… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Paclitaxel exhibits clinical activity against a wide variety of solid tumors. However, resistance to paclitaxel significantly… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
UNLABELLED Angiogenesis is a critical step in tumor development, in which vascular endothelial growth factor (VEGF) is a key… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Background:Heat-shock protein 90 (Hsp90) has a crucial role in both the stabilisation and regulation of various proteins… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2010
2010
1Department of Medical Oncology, University of Groningen, Groningen, The Netherlands; 2Department of Pathology, University of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Shifting substrate oxidation in heart muscle from fatty acids to glucose (substrate-switch) may improve contractile function in… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 1
Is this relevant?
2008
2008
An attractive target for therapeutic intervention is constitutively activated, mutant FLT3, which is expressed in a subpopulation… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Dipeptidyl peptidase IV (DPP-IV) inhibition has the potential to become a valuable therapy for type 2 diabetes. The synthesis and… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVES Inhibitors of the glucagon-like peptide-1 (GLP-1)-degrading enzyme, dipeptidyl peptidase IV (DPPIV), are being… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE Glucagon-like peptide-1 (GLP-1) has been proposed as a new treatment modality for type 2 diabetes. To circumvent the… Expand
  • figure 1—24
  • figure 2
  • table 1
  • table 2
Is this relevant?